Invention Grant
- Patent Title: Human phosphatase RET31, and variants thereof
- Patent Title (中): 人磷酸酶RET31及其变体
-
Application No.: US11143984Application Date: 2005-06-02
-
Publication No.: US07358074B2Publication Date: 2008-04-15
- Inventor: Donald G. Jackson , Chandra S. Ramanathan , Liana Lee , Nathan Siemers , Suzanne J. Suchard , Joshua Finger , C. Gordon Todderud , Dana Banas
- Applicant: Donald G. Jackson , Chandra S. Ramanathan , Liana Lee , Nathan Siemers , Suzanne J. Suchard , Joshua Finger , C. Gordon Todderud , Dana Banas
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Stephen C. D'Amico
- Main IPC: C12N9/16
- IPC: C12N9/16 ; C12N1/20 ; C12N15/63 ; C12P21/00 ; C12P21/04 ; C12P21/06 ; C07H21/04
Abstract:
The present invention provides novel polynucleotides encoding human phosphatase polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel human phosphatase polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
Public/Granted literature
- US20060014180A1 Human phosphatase RET31, and variants thereof Public/Granted day:2006-01-19
Information query
